Different treatment modalities and outcomes in cesarean scar pregnancy: a retrospective analysis of 31 cases in a university hospital


ORHAN A., KASAPOĞLU I., Demir B., ÖZERKAN K., DÜZOK N., UNCU G.

GINEKOLOGIA POLSKA, no.6, pp.291-307, 2019 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Publication Date: 2019
  • Doi Number: 10.5603/gp.2019.0053
  • Journal Name: GINEKOLOGIA POLSKA
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.291-307
  • Keywords: Cesarean scar pregnancy, treatment modalities, Morbidly adherent placenta, ECTOPIC PREGNANCY, MANAGEMENT, PLACENTA, DIAGNOSIS, CURETTAGE, ACCRETA
  • Bursa Uludag University Affiliated: Yes

Abstract

Objectives: There is no standardized treatment modality or a generally accepted guideline in cesarean scar pregnancy (CSP) treatment. The aim of this study is to retrospectively evaluate the outcomes of the different treatment modalities used in CSP treatment. Material and methods: 31 CSP patients retrospectively evaluated between May 2011 and February at Uludag University Hospital in Bursa, Turkey included in the study. A graphical flowchart according to the treatment modalities and timeline graphics of the patients were used. Main outcome measures were recurrent CSPs and healthy pregnancies in clinical follow-up after a successful CSP treatment. Results: 31 CSP patients were treated with six different treatment modalities in our series. Recurrent CSP was diagnosed in three patients after a successful CSP treatment. All of these recurrent CSPs were treated with O/C procedure in their first CSP. Six patients conceived again in clinical follow-up after successful treatment of CSP. Conclusions: CSP is a serious maternal complication that risks the mother's life, and this problem is growing because of the increased cesarean rates. Invasive procedures applied to the uterus in CSP treatment may cause recurrent CSP in the next pregnancy of the patient. When considering the treatment options of the CSP, minimally invasive treatment modalities and the subsequent gestation of the patient should be taken into account.